IBD4 |
|
inflammatory bowel disease 4
|
|
|
0.890 |
0.077 |
CD37 |
P11049
|
CD37 molecule
|
|
4.4E-06 |
0.647 |
0.462 |
CDAN1 |
Q8IWY9
|
codanin 1
|
|
1.1E-12 |
0.610 |
0.731 |
CREB3L1 |
Q96BA8
|
cAMP responsive element binding protein 3 like 1
|
|
0.98 |
0.601 |
0.615 |
WDHD1 |
O75717
|
WD repeat and HMG-box DNA binding protein 1
|
Nucleic acid binding
|
4.4E-18 |
0.529 |
0.846 |
ACAN |
P16112
|
aggrecan
|
Extracellular structure
|
1.00 |
0.528 |
0.846 |
CD74 |
P04233
|
CD74 molecule
|
Enzyme modulator
|
0.25 |
0.512 |
0.808 |
CRYGD |
P07320
|
crystallin gamma D
|
|
3.0E-04 |
0.510 |
0.808 |
BMP7 |
P18075
|
bone morphogenetic protein 7
|
Signaling
|
0.13 |
0.498 |
0.769 |
VCAN |
P13611
|
versican
|
Extracellular structure
|
1.00 |
0.497 |
0.808 |
ACR |
P10323
|
acrosin
|
Enzyme
|
1.2E-02 |
0.493 |
0.846 |
RYR1 |
P21817
|
ryanodine receptor 1
|
Ion channel
|
1.6E-29 |
0.489 |
0.808 |
SOST |
Q9BQB4
|
sclerostin
|
|
0.87 |
0.474 |
0.808 |
IL23R |
Q5VWK5
|
interleukin 23 receptor
|
Signaling
|
5.6E-04 |
0.466 |
0.769 |
HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
MEFV |
O15553
|
MEFV innate immuity regulator, pyrin
|
|
1.0E-14 |
0.440 |
0.885 |
DKK1 |
O94907
|
dickkopf WNT signaling pathway inhibitor 1
|
|
0.17 |
0.439 |
0.885 |
BMP2 |
P12643
|
bone morphogenetic protein 2
|
Signaling
|
0.99 |
0.432 |
0.846 |
NOD2 |
Q9HC29
|
nucleotide binding oligomerization domain containing 2
|
Enzyme
|
2.0E-30 |
0.423 |
0.923 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
CD68 |
P34810
|
CD68 molecule
|
Transporter
|
1.4E-06 |
0.408 |
0.808 |
RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
POMC |
P01189
|
proopiomelanocortin
|
|
1.2E-04 |
0.356 |
0.846 |